Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online January 25, 2008
Diabetes 57:1236-1245, 2008
DOI: 10.2337/db07-0844
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-0844v1
57/5/1236    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Dogusan, Z.
Right arrow Articles by Rasschaert, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dogusan, Z.
Right arrow Articles by Rasschaert, J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Double-Stranded RNA Induces Pancreatic β-Cell Apoptosis by Activation of the Toll-Like Receptor 3 and Interferon Regulatory Factor 3 Pathways

Zeynep Dogusan1, Mónica García1, Daisy Flamez1, Lena Alexopoulou2, Michel Goldman3, Conny Gysemans4, Chantal Mathieu4, Claude Libert5, Decio L. Eizirik1, and Joanne Rasschaert1

1 Laboratory of Experimental Medicine, Université Libre de Bruxelles, Brussels, Belgium
2 Centre d'Immunologie de Marseille-Luminy, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Université de la Mediterranée, Marseille, France
3 Institute of Medical Immunology, Université Libre de Bruxelles, Charleroi, Belgium
4 Laboratory of Experimental Medicine and Endocrinology (Legendo), Universitaire Ziekenhuizen Gasthuisberg O&N, Katholieke Universiteit Leuven, Leuven, Belgium
5 Department for Molecular Biomedical Research, VIB Ghent University, Ghent, Belgium

Corresponding author: Dr. Joanne Rasschaert, Laboratory of Experimental Medicine, Université Libre de Bruxelles, Route de Lennik, 808, CP 618, B-1070 Brussels, Belgium. E-mail: jrasscha{at}ulb.ac.be

Abbreviations: ATF-4, activating transcription factor-4; CHOP, CCAAT/enhancer-binding protein homologous protein; dsRNA, double-stranded RNA; eIF, eukaryotic initiation factor; ER, endoplasmic reticulum; FACS, fluorescence-activated cell sorter; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; IFNAR1, type I interferon receptor; IFN, interferon; IL, interleukin; IRF, interferon regulatory factor; LF, lipofectamine; NF-{kappa}B, nuclear factor-{kappa}B; PIC, polyinosinic-polycytidylic acid; PKR, dsRNA-dependent protein kinase; TLR, toll-like receptor

OBJECTIVE— Viral infections contribute to the pathogenesis of type 1 diabetes. Viruses, or viral products such as double-stranded RNA (dsRNA), affect pancreatic β-cell survival and trigger autoimmunity by unknown mechanisms. We presently investigated the mediators and downstream effectors of dsRNA-induced β-cell death.

RESEARCH DESIGN AND METHODS— Primary rat β-cells and islet cells from wild-type, toll-like receptor (TLR) 3, type I interferon receptor (IFNAR1), or interferon regulatory factor (IRF)-3 knockout mice were exposed to external dsRNA (external polyinosinic-polycytidylic acid [PICex]) or were transfected with dsRNA ([PICin]).

RESULTS— TLR3 signaling mediated PICex-induced nuclear factor-{kappa}B (NF-{kappa}B) and IRF-3 activation and β-cell apoptosis. PICin activated NF-{kappa}B and IRF-3 in a TLR3-independent manner, induced eukaryotic initiation factor 2{alpha} phosphorylation, and triggered a massive production of interferon (IFN)-β. This contributed to β-cell death, as islet cells from IFNAR1–/– or IRF-3–/– mice were protected against PICin-induced apoptosis.

CONCLUSIONS— PICex and PICin trigger β-cell apoptosis via the TLR3 pathway or IRF-3 signaling, respectively. Execution of PICin-mediated apoptosis depends on autocrine effects of type I IFNs.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.